New guidelines for the clinical management of febrile neutropenia and sepsis in pediatric oncology patients

被引:0
|
作者
Almeida Mendes, Ana Verena [1 ,2 ]
Sapolnik, Roberto [3 ]
Mendonca, Nubia [4 ]
机构
[1] Univ Sao Paulo, Sao Paulo, SP, Brazil
[2] Escola Bahiana Med & Saude Publ, Salvador, BA, Brazil
[3] Univ Fed Bahia, Salvador, BA, Brazil
[4] Sociedade Oncol Bahia ONCO, Ser Oncol Pediat, Salvador, BA, Brazil
关键词
D O I
10.2223/JPED.1624
中图分类号
R72 [儿科学];
学科分类号
100202 ;
摘要
Objectives: To provide a foundation for the diagnostic, prophylactic and therapeutic management of febrile neutropenia and sepsis in children with oncological diseases, with special attention to new protocols and guidelines. Sources: A review of the scientific literature utilizing an electronic bibliographic search on MEDLINE, Medscape, SciELO, Google, Cochrane and PubMED using the keywords febrile, neutropenic, cancer, children, sepsis, intensive, care. Articles published between 1987 and 2007 were selected, with preference given to review articles, protocols, systematic reviews, epidemiological studies, task force recommendations and phase III clinical trials. Consensus documents published by the Infectious Diseases Society of America, the Center for Diseases Control and the Infectious Diseases Working Party of the German Society of Hematology and Oncology, in addition to the recommendations of the World Federation of Pediatric Intensive and Critical Care Societies and Society of Critical Care Medicine, were also reviewed. Summary of the findings: The use of aggressive chemotherapy regimens, bone marrow transplantation and intensive care resources have increased the survival rates of children with cancer and also their infectious morbidity, with septic complications as the principal cause of mortality. Several risk factors have been identified, such as neutropenia, oncology type, clinical signs and inflammatory response markers (polymerase chain reaction, procalcitonin) and also increased resistance to antimicrobials and antifungal agents. Protocols for risk classification, diagnosis and treatment should be established at each service, taking into account the microbiological flora of each population. Pediatric intensive care has increased the short and long-term survival of these patients. Conclusions: Oncology patients are particularly vulnerable to infectious complications. Early identification and treatment are fundamental to improving survival rates.
引用
收藏
页码:S54 / S63
页数:10
相关论文
共 50 条
  • [31] Use of fluoroquinolones for empirical management of febrile neutropenia in pediatric cancer patients
    Freifeld, A
    Pizzo, P
    [J]. PEDIATRIC INFECTIOUS DISEASE JOURNAL, 1997, 16 (01) : 140 - 146
  • [32] Immune signatures, testing, and management of febrile neutropenia in pediatric cancer patients
    Bochennek, Konrad
    Hogardt, Michael
    Lehrnbecher, Thomas
    [J]. EXPERT REVIEW OF CLINICAL IMMUNOLOGY, 2023, 19 (03) : 267 - 277
  • [33] Pediatric Oncology Discharges With Febrile Neutropenia: Variation in Location of Care
    Alvarez, Elysia
    Chamberlain, Lisa J.
    Aftandilian, Catherine
    Saynina, Olga
    Wise, Paul
    [J]. JOURNAL OF PEDIATRIC HEMATOLOGY ONCOLOGY, 2017, 39 (01) : E1 - E7
  • [34] MANAGEMENT AND COST OF FEBRILE NEUTROPENIA (FN) IN THE ONCOLOGY PATIENT
    van Gogh, E.
    Specenier, P.
    Strens, D.
    [J]. VALUE IN HEALTH, 2019, 22 : S453 - S453
  • [35] Low risk febrile neutropenia in oncological pediatric patients: clinical experience
    Rojo L, Claudia
    Rodriguez Z, Natalie
    Tordecilla C, Juan
    [J]. REVISTA CHILENA DE PEDIATRIA-CHILE, 2008, 79 (02): : 157 - 162
  • [36] "Golden Hour" Intervention as a Predictor of Morbidity and Mortality in Pediatric Oncology Patients With Febrile Neutropenia
    Leon, J.
    Ruiz, M.
    Macias, L.
    Cervantes, A.
    [J]. PEDIATRIC BLOOD & CANCER, 2020, 67 : S375 - S375
  • [37] INTERLEUKIN-8 VALUES IN PEDIATRIC ONCOLOGY PATIENTS WITH FEBRILE NEUTROPENIA AND BLOODSTREAM INFECTIONS
    Urbonas, V.
    Eidukaite, A.
    Tamuliene, I.
    [J]. PEDIATRIC RESEARCH, 2011, 70 : 490 - 490
  • [38] Interleukin-8 Values in Pediatric Oncology Patients with Febrile Neutropenia and Bloodstream Infections
    V Urbonas
    A Eidukaite
    I Tamuliene
    [J]. Pediatric Research, 2011, 70 : 490 - 490
  • [39] Febrile neutropenia risk assessment tool: Improving clinical outcomes for oncology patients
    O'Brien, Catherine
    Dempsey, Orla
    Kennedy, M. John
    [J]. EUROPEAN JOURNAL OF ONCOLOGY NURSING, 2014, 18 (02) : 167 - 174
  • [40] Outpatient versus inpatient IV antibiotic management for pediatric oncology patients with low risk febrile neutropenia: A randomised trial
    Orme, Lisa M.
    Babl, Franz E.
    Barnes, Chris
    Barnett, Peter
    Donath, Susan
    Ashley, David M.
    [J]. PEDIATRIC BLOOD & CANCER, 2014, 61 (08) : 1427 - 1433